NEW BRUNSWICK, N.J., March 16, 2011 /PRNewswire-USNewswire/ —
Working with the Foundation of UMDNJ and New Jersey Health
Foundation, Rostock Biotech Research Ltd, headquartered in Moscow,
Russia, has donated $100,000 to fund the research of Dr. Alexey G.
Ryazanov, a professor in the Department of Pharmacology at
UMDNJ-Robert Wood Johnson Medical School (RWJMS) and a member of
The Cancer Institute of New Jersey.
The Blue Sky Research and Development Fund in Pharmacology in
the Department of Pharmacology allows Dr. Ryazanov to investigate
cellular and molecular mechanisms of aging and age-related diseases
and to pursue research that would lead to better understanding of
the fundamental principles of drug action.
“This funding permits Dr. Ryazanov to pursue cutting edge
research without limitations on ideas or hypothesis,” explained
Dmitri Khan of Rostock Group, parent of Rostock Biotech Research.
“We hope it will open the door for Dr. Ryazanov and his team to
make unlimited discoveries that will have a positive impact in the
future.”
Working in concert with donors, the Foundation of UMDNJ/New
Jersey Health Foundation can develop fund agreements that are
individually tailored to meet donor needs.
“Because many of our donors wish to remain connected to the
areas they help fund, this agreement, like many others we have
developed, provides an opportunity for representatives from Rostock
to meet with department representatives periodically to discuss
innovative findings that might come about as a result of this
research,” explained George F. Heinrich, M.D., vice chair and CEO
of the Foundation. “It’s very exciting for a researcher to be
able to share his or her results with others who are passionate
about their work.”
To learn more about how you can fund research in an area that
means the most to you, contact James M. Golubieski, Foundation
president, at (908) 731-6601 or
jgolubiesk
‘/>”/>
SOURCE